Drug recall D-0649-2024
Product
Heparin (Heparin Sodium in 0.9% Sodium Chloride Injection), 2,000 units per 1,000 mL (2 units/mL), 1000 mL Sterile Single Dose Container, Rx Only, Baxter USA, NDC 0338-0433-04
Reason for recall
Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
Lots and codes
Lot # N008235, Exp 8/31/2024
Recall details
- Recalling firm
- Baxter Healthcare Corporation, Round Lake, IL
- Quantity
- 44,208 containers
- Distribution
- Nationwide in the USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- August 1, 2024
Related products
- Heparin Sodium in Sodium Chloride – drug information
- NDC 0338-0428 Heparin Sodium In Sodium Chloride · Heparin Sodium 200 [USP'U]/100mL · Baxter Healthcare Corporation
- NDC 0338-0431 Heparin Sodium In Sodium Chloride · Heparin Sodium 200 [USP'U]/100mL · Baxter Healthcare Corporation
- NDC 0338-0424 Heparin Sodium In Sodium Chloride · Heparin Sodium 200 [USP'U]/100mL · Baxter Healthcare Corporation
- NDC 0338-0433 Heparin Sodium In Sodium Chloride · Heparin Sodium 200 [USP'U]/100mL · Baxter Healthcare Corporation